BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Smyk DS, Rigopoulou EI, Pares A, Billinis C, Burroughs AK, Muratori L, Invernizzi P, Bogdanos DP. Sex differences associated with primary biliary cirrhosis. Clin Dev Immunol. 2012;2012:610504. [PMID: 22693524 DOI: 10.1155/2012/610504] [Cited by in Crossref: 18] [Cited by in F6Publishing: 19] [Article Influence: 1.8] [Reference Citation Analysis]
Number Citing Articles
1 Rigopoulou EI, Bogdanos DP. Is primary biliary cirrhosis rare or common? The truth lies somewhere in between. Liver Int 2014;34:e165-7. [PMID: 24517310 DOI: 10.1111/liv.12488] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
2 Koutsoumpas AL, Kriese S, Rigopoulou EI. Popular and unpopular infectious agents linked to primary biliary cirrhosis. Auto Immun Highlights 2012;3:95-104. [PMID: 26000132 DOI: 10.1007/s13317-012-0039-y] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
3 Liu WY, Xiao L, Yin H, Zhan XY, Zhang ZG, Lu XB, Zhang YX. Clinical and pathological features of primary biliary cirrhosis in anti-mitochondria antibody/anti-mitochondrial antibody M2 subtype negative patients. Shijie Huaren Xiaohua Zazhi 2013; 21(34): 3799-3805 [DOI: 10.11569/wcjd.v21.i34.3799] [Reference Citation Analysis]
4 Bianchi I, Lleo A, Bernuzzi F, Caliari L, Smyk DS, Invernizzi P. The X-factor in primary biliary cirrhosis: monosomy X and xenobiotics. Auto Immun Highlights 2012;3:127-32. [PMID: 26000136 DOI: 10.1007/s13317-012-0043-2] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
5 Wang X, Wen X, Zhou J, Qi Y, Wu R, Wang Y, Kui Y, Hua R, Jin Q. MicroRNA-223 and microRNA-21 in peripheral blood B cells associated with progression of primary biliary cholangitis patients. PLoS One 2017;12:e0184292. [PMID: 28886078 DOI: 10.1371/journal.pone.0184292] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
6 Kur P, Kolasa-Wołosiuk A, Misiakiewicz-Has K, Wiszniewska B. Sex Hormone-Dependent Physiology and Diseases of Liver. Int J Environ Res Public Health 2020;17:E2620. [PMID: 32290381 DOI: 10.3390/ijerph17082620] [Cited by in Crossref: 19] [Cited by in F6Publishing: 18] [Article Influence: 9.5] [Reference Citation Analysis]
7 Guo GL. Why is the female population more susceptible to cholestasis-induced liver injury-Could it be long noncoding RNA H19? Hepatology 2017;66:694-6. [PMID: 28508397 DOI: 10.1002/hep.29255] [Reference Citation Analysis]
8 Petrescu AD, Grant S, Frampton G, Kain J, Hadidi K, Williams E, McMillin M, DeMorrow S. Glucocorticoids Cause Gender-Dependent Reversal of Hepatic Fibrosis in the MDR2-Knockout Mouse Model. Int J Mol Sci 2017;18:E2389. [PMID: 29125588 DOI: 10.3390/ijms18112389] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.6] [Reference Citation Analysis]
9 Shahoei SH, Kim YC, Cler SJ, Ma L, Anakk S, Kemper JK, Nelson ER. Small Heterodimer Partner Regulates Dichotomous T Cell Expansion by Macrophages. Endocrinology 2019;160:1573-89. [PMID: 31050726 DOI: 10.1210/en.2019-00025] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
10 Hudspeth K, Pontarini E, Tentorio P, Cimino M, Donadon M, Torzilli G, Lugli E, Della Bella S, Gershwin ME, Mavilio D. The role of natural killer cells in autoimmune liver disease: a comprehensive review. J Autoimmun. 2013;46:55-65. [PMID: 23880068 DOI: 10.1016/j.jaut.2013.07.003] [Cited by in Crossref: 59] [Cited by in F6Publishing: 59] [Article Influence: 6.6] [Reference Citation Analysis]
11 Qin B, Huang F, Liang Y, Yang Z, Zhong R. Analysis of altered microRNA expression profiles in peripheral blood mononuclear cells from patients with primary biliary cirrhosis. J Gastroenterol Hepatol. 2013;28:543-550. [PMID: 23173724 DOI: 10.1111/jgh.12040] [Cited by in Crossref: 30] [Cited by in F6Publishing: 28] [Article Influence: 3.3] [Reference Citation Analysis]
12 Buzzetti E, Parikh PM, Gerussi A, Tsochatzis E. Gender differences in liver disease and the drug-dose gender gap. Pharmacol Res 2017;120:97-108. [PMID: 28336373 DOI: 10.1016/j.phrs.2017.03.014] [Cited by in Crossref: 30] [Cited by in F6Publishing: 27] [Article Influence: 6.0] [Reference Citation Analysis]
13 Johnson AM, Akpan EJ, Kale S, Patel A. A Rare Case Presentation: Diagnosing Primary Biliary Cholangitis in a Male Patient With Concomitant Type 1 Diabetes. Cureus 2021;13:e16109. [PMID: 34367753 DOI: 10.7759/cureus.16109] [Reference Citation Analysis]
14 Zakharia K, Tabibian A, Lindor KD, Tabibian JH. Complications, symptoms, quality of life and pregnancy in cholestatic liver disease. Liver Int. 2018;38:399-411. [PMID: 28921801 DOI: 10.1111/liv.13591] [Cited by in Crossref: 13] [Cited by in F6Publishing: 15] [Article Influence: 2.6] [Reference Citation Analysis]
15 Ma WT, Liu QZ, Yang JB, Yang YQ, Zhao ZB, Ma HD, Gershwin ME, Lian ZX. A Mouse Model of Autoimmune Cholangitis via Syngeneic Bile Duct Protein Immunization. Sci Rep 2017;7:15246. [PMID: 29127360 DOI: 10.1038/s41598-017-15661-6] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
16 Angele MK, Pratschke S, Hubbard WJ, Chaudry IH. Gender differences in sepsis: cardiovascular and immunological aspects. Virulence 2014;5:12-9. [PMID: 24193307 DOI: 10.4161/viru.26982] [Cited by in Crossref: 142] [Cited by in F6Publishing: 132] [Article Influence: 15.8] [Reference Citation Analysis]
17 Huang YQ. Recent advances in understanding the pathogenesis of primary biliary cirrhosis. Shijie Huaren Xiaohua Zazhi 2012; 20(29): 2761-2770 [DOI: 10.11569/wcjd.v20.i29.2761] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
18 Smyk DS, Rigopoulou EI, Bogdanos DP. Potential Roles for Infectious Agents in the Pathophysiology of Primary Biliary Cirrhosis: What’s New? Curr Infect Dis Rep. 2013;15:14-24. [PMID: 23188623 DOI: 10.1007/s11908-012-0304-2] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 1.7] [Reference Citation Analysis]
19 Franco I, Dubini A, Piciucchi S, Casoni G, Poletti V. Interstitial lung disease preceding primary biliary cirrhosis in a male patient. Rev Port Pneumol (2006). 2015;21:214-217. [PMID: 25998779 DOI: 10.1016/j.rppnen.2015.02.008] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
20 Malik A, Kardashian AA, Zakharia K, Bowlus CL, Tabibian JH. Preventative care in cholestatic liver disease: Pearls for the specialist and subspecialist. Liver Res 2019;3:118-27. [PMID: 32042471 DOI: 10.1016/j.livres.2019.04.001] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
21 Vignoli A, Orlandini B, Tenori L, Biagini MR, Milani S, Renzi D, Luchinat C, Calabrò AS. Metabolic Signature of Primary Biliary Cholangitis and Its Comparison with Celiac Disease. J Proteome Res 2019;18:1228-36. [PMID: 30539636 DOI: 10.1021/acs.jproteome.8b00849] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 4.3] [Reference Citation Analysis]